Asset impairment issues for hospitals to consider in the wake of COVID-19
For health systems, the decline in financial performance due to COVID-19 creates a triggering event for interim or annual impairment testing of certain assets on the balance sheet.
Medicare considering making telehealth expansion permanent, Verma says
Medicare is considering making permanent some of the temporary telehealth waivers it has issued during the pandemic.
With 40% of COVID deaths, post-acute care sites get funding, scrutiny
COVID-19 focus and assistance increasingly have been turning to post-acute care providers.
Federal payments for care of uninsured COVID-19 patients to go out in mid-May
Hospitals that have tested or treated uninsured patients for COVID-19 can start receiving federal payments as soon as mid-May.
HHS identifies limits on clawbacks of CARES Act overpayments
HHS will limit reclamation of COVID-19 assistance to amounts higher than related expenses and lost revenues.
Hospitals shed 135,000 jobs in April while losing an estimated $51 billion
Hospitals shed 3% of their workforce in April as the coronavirus and related government policies led to an estimated $51 billion revenue loss.
Some hospitals pursue coronavirus assistance through FEMA — the ‘payer of last resort’
Hospitals are seeking FEMA funding to cover expenses incurred as part of their coronavirus responses.
CMS seeks healthcare provider comments on possible new methodology to calculate MS-DRG weights
HFMA's Chad Mulvany reviews possible technical and legal challenges CMS may face as it proposes to collect provider pricing data.
Rolling forecasting will help get hospitals through the COVID-19 crisis
The upheaval hospitals and health systems are experiencing as a result of the COVID-19 pandemic has made traditional annual budgeting processes inadequate. Organizations should consider adopting instead a budgeting process based on rolling forecasting.
U.S. District judge hears CMS price transparency lawsuit opening arguments
The May 7 hearing regarding CMS's controversial price transparency policy is likely the opening act in what may be a long series of appeals to the lawsuit filed against the Trump administration.